Acne

In this exclusive interview with Dermatology Times, David Goldberg, MD, JD, explains why lasers are a treatment option in acne and the latest advancements in the field.

In this exclusive video interview with Dermatology Times, Michael Gold, MD, tells us about his session at the New Frontiers in Cosmetic Medicine and Medical Dermatology Symposium.

Sun Pharma has announced that their Winlevi 1% cream is now available in the US to treat acne vulgaris in patients 12 years and older.

Racial disparities in antibiotic prescription also influence treatment decisions.

A study investigated the role diet habits have in the development, duration, and severity of acne.

Two published studies investigated the safety and efficacy of oral sarecycline for the treatment of truncal acne.

Which is more worrisome, neonatal or infantile acne? An expert answered this question and more during Maui Derm NP+PA Fall 2021’s update on acne and rosacea.

A recent case report highlights the importance of caution when using fractional laser resurfacing in patients with active or previous acne.

In this week’s Pointers with Dr Portela, the 208SkinDoc and Cassandra Bankson, a medical aesthetician and skin advocate, react to cystic acne TikToks and offer commentary.

At the 2021 Skin of Color Update, Andrew Alexis, MD, MPH, presented on the subtle distinctions in treating skin of color patients with acne.

Click here to answer our weekly poll.

This week’s Pointers With Dr Portela, Dustin Portela, DO, explains pimple patches and hydrocolloid patches, diving into how to treat acne when it surfaces.

Testosterone therapy often leads to unique challenges.

A review article investigated the psychological effects acne has on adolescent patients.

A survey conducted by Acne Wipeout and OnePoll found that Americans miss out on dating, school, hanging out with friends, and work meetings because of their skin.

A recent study investigated the difference between skin microbiota in patients with acne and controls without acne.

A study published in JAMA Dermatology investigated the strain acne puts on the lives of adult women.

Joshua Zeichner, MD, associate professor of dermatology and director of cosmetic & clinical research in dermatology, Mount Sinai Hospital, New York, discusses the impact of the recent FDA approval of Twyneo (Sol-Gel) for the treatment of acne.

Here are best practices in understanding scar morphology, building patient trust, and choosing treatment.

Twyneo, a tretinoin and benzoyl peroxide cream, has been approved by the FDA for the treatment of acne vulgaris in patients 9 years and older.

A study in the Journal of Drugs in Dermatology gathered a panel of skin of color experts to examine acne treatment in patients with skin of color.

Nasal papules that are histologically indistinguishable from angiofibroma may be a sequela of acne.

IDP-126, an acne vulgaris treatment for patients ages 9 and older, met all of its endpoints in a 12-week phase 3 study.

American Academy of Dermatology’s updated guidelines on acne will cover dermatology’s hottest issues, from dosing and monitoring established medications to exploring new antibiotics and addressing antibiotic stewardship.

Emmy Graber, MD, presented the updates in acne and rosacea treatments at the SCALE Acne and Rosacea update on June 9, 2021.